Devices › Device types
FDA product code OOI · class 2 · Clinical Chemistry
Real time nucleic acid amplification system: medical device reports filed with FDA
2,778 reports carry this product code, 2011–2026; 3 brands with a page.
- 2,778
- reports with this product code
- 0% of all MAUDE reports
- 563
- reports, 12 months to August 2026
- 487 in the 12 months before
- 98.9%
- classified as malfunction
- 62.3% across all reports
- 0%
- classified as death, as reported
- 0.9% across all reports
Product code OOI is FDA's classification for "Real time nucleic acid amplification system" (clinical Chemistry panel), a class 2 device. 2,778 medical device reports carry this product code, 0% of the MAUDE database, from April 2011 to August 2026.
563 reports arrived in the 12 months to August 2026, up 16% from 487 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (98.9%), injury (0.9%) and other (0.1%). 3 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| BD MAX System, BD MAX Instrument | 1,076 | 252 | 0% | 99.6% |
| Alinity m System | 966 | 74 | 0% | 99.3% |
| Bd Bactec Fx Instrument Top Packaged | 1 | 0 | 0.2% | 99.8% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Becton Dickinson & Sparks | 1,189 | 42.8% |
| Abbott Molecular | 979 | 35.2% |
| Becton Dickinson | 69 | 2.5% |
| Abbott Diagnostics Scarborough | 45 | 1.6% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| False positive result | 1,237 | 44.5% |
| Incorrect, inadequate or imprecise result or readings | 339 | 12.2% |
| Program or algorithm execution problem | 316 | 11.4% |
| Fluid/blood leak | 264 | 9.5% |
| Device dislodged or dislocated | 194 | 7% |
| False negative result | 143 | 5.1% |
| Unable to obtain readings | 80 | 2.9% |
| Mechanical problema mechanical problem | 56 | 2% |
| Structural problem | 56 | 2% |
| Smoking | 22 | 0.8% |
| Human-device interface problem | 11 | 0.4% |
| Breakthe device broke | 8 | 0.3% |
| Defective devicethe device was defective | 6 | 0.2% |
| Device operates differently than expectedthe device behaved unexpectedly | 6 | 0.2% |
| Sparking | 6 | 0.2% |
| Detachment of device or device componentpart of the device came off | 5 | 0.2% |
| Temperature problem | 5 | 0.2% |
| Device displays incorrect message | 4 | 0.1% |
| Leak/splashthe device leaked | 4 | 0.1% |
| Nonstandard device | 4 | 0.1% |
Questions about real time nucleic acid amplification system reports
What is product code OOI?
FDA's classification code for "Real time nucleic acid amplification system", class 2, reviewed by the clinical Chemistry panel. Every device report carries the product code of the device involved.
How many reports carry this code?
2,778 reports through August 2026, 563 of them in the latest 12 months.
Which brands appear most often?
BD MAX System, BD MAX Instrument (1,076), Alinity m System (966) and Bd Bactec Fx Instrument Top Packaged (1). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.